SARS-CoV-2 main protease (3CL(pro)) interaction with acyclovir antiviral drug/methyl-β-cyclodextrin complex: Physiochemical characterization and molecular docking

During the current outbreak of the novel coronavirus disease 2019 (COVID-19), researchers have examined several antiviral drugs with the potential to inhibit the proliferation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The antiviral drug acyclovir (AVR), which is used to tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohandoss, Sonaimuthu, Sukanya, Ramaraj, Ganesan, Sivarasan, Alkallas, Fatemah H., Ben Gouider Trabelsi, Amira, Kusmartsev, Fedor V., Sakthi Velu, Kuppu, Stalin, Thambusamy, Lo, Huang-Mu, Rok Lee, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458544/
https://www.ncbi.nlm.nih.gov/pubmed/36101854
http://dx.doi.org/10.1016/j.molliq.2022.120292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458544/
https://www.ncbi.nlm.nih.gov/pubmed/36101854
http://dx.doi.org/10.1016/j.molliq.2022.120292

Ejemplares similares